Drug Discovery Technologies

World Market Report

MCP-1506

EXECUTIVE ENGAGEMENTS

POOL

11069
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1328
Interactions with Platform & by Email

PARTICIPANTS

332
Unique # Participated

VALIDATIONS

82
Responses Validated*

COMPANIES

129
Responses Validated*
* Login for a full stack data experience

DATE

JAN 2023

TABLES

150

PAGES

486

EDITION

20

PRICE

USD 5450

CODE

MCP-1506


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

RANK

(S/A/N/T)

%

VALIDATED RESEARCH *

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What`s New for 2023?

» Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Drug Discovery Technologies Market to Reach $85.9 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Drug Discovery Technologies estimated at US$49.9 Billion in the year 2020, is projected to reach a revised size of US$85.9 Billion by 2027, growing at aCAGR of 8.1% over the period 2020-2027. Small Molecule Drugs, one of the segments analyzed in the report, is projected to record 7.8% CAGR and reach US$64.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Biologics segment is readjusted to a revised 8.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $15.5 Billion, While China is Forecast to Grow at 10.1% CAGR
The Drug Discovery Technologies market in the U.S. is estimated at US$15.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$14 Billion by the year 2027 trailing a CAGR of 10.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.3% and 6.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.9% CAGR.

SELECT PLAYERS

Affymetrix Inc.; Agilent Technologies, Inc.; Curia Global, Inc.; Astrazeneca plc; Bayer Healthcare AG; Bio-Rad Laboratories Inc.; Charles River Laboratories International Inc.; Evotec Ag; GYROS PROTEIN TECHNOLOGIES AB; Illumina, Inc.; Luminex Corporation; Merck KGaA; Molecular Discovery Ltd.; Novartis AG; Thermo Fisher Scientific Inc.

SEGMENTS

» Type (Small Molecule Drugs, Biologics) » Technology (High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology, Other Technologies) » End-Use (Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Other End-Uses)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Drug Discovery Technologies – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
A Prelude to Drug Discovery Technologies
Impact of Pandemic on Drug Discovery Market
Global Market Analysis and Prospects
Global Drug Discovery Technologies Market Set to Witness Rapid Growth
Regional Market Analysis
Market Analysis based on Application
Market Analysis based on End-User
Competition
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Late-Stage Drug Failures Drives Demand for Drug Discovery Technolgies
Exhibit 2: Average Cost of Drug Development (In Us$ Billion) in the US Since 1980s
EXHIBIT 4: Factors Leading to Failure of Drugs in Phase III Clinical Trials: Percentage Breakdown of Number of Cases for Efficacy, Pharmacokinetics, Toxicity and Others
Cell-based Assays Play a Critical Role in Drug Discovery
TABLE 1: Cell-based Assays Market by Application (2020): Percentage Share Breakdown of Value Sales for Drug Discovery, ADME Testing, and Basic Research
Major Types of Cell-Based HTS Assays for Drug Screening
TABLE 2: Global Cell-based Assays Market by Segment (2020): Percentage Share Breakdown of Value Sales for Consumables, Instruments, Software, and Services
High-Content Screening (HCS) - An Expanding Technology in Cell-Based Assays
High Content Screening - Key Application Areas
Technology Advances in Drug Discovery Processes
Increased Demand of Biochips in Drug Discovery to Drive Market Growth
Increased Demand for Personalized Medicine to Drive Drug Discovery Technologies Market
EXHIBIT 3: Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
Proteomics and Genomics Drive Opportunities for Drug Discovery Technologies
Proteomics Profiling to Expedite Drug Discovery
Other Applications of Proteomics in Drug Discovery
New Proteomics Technique to Aid Drug Screening & Biomarker Discovery
Proteomic Approaches Gain Prominence in Cancer Drug Discovery
Proteomics Technologies Used in Cancer Drug Discovery and Development
Role of Proteomics in Oncology Biomarker Discovery
Gaining Insights into COVID-19 & Drug Discovery with Proteomics
Bioinformatics Tools along with Proteomics Accelerate the Process of Pathway Prediction
Using AI in Drug Discovery: The Latest Market Research
High-throughput Screening (HTS) – A Key Drug Discovery Technology
HTS: Making Use of a Smarter Approach to Hit Discovery
Emerging Technologies in Drug Discovery and Development
Targeted Drug Development and Discovery
Significance of Advanced Clinical Sequencing for Drug Developers
Metabolomics: An Emerging Trend in Drug Discovery
Impact of ADME-Tox Screening on New Drug Discovery
EXHIBIT 3: Phase-I Clinical Trial Failures Before and After the Advent of Preclinical ADME/Pharmacokinetics
Pharma Industry Renews Focus on Cost Optimization
EXHIBIT 6: Global Pharmaceutical R&D Spending (US$ Billion) for the Years 2011 through 2020
China and India: Hot Spots for R&D Investment
EXHIBIT 8: World R&D Market by Geographic Region (2020): Percentage Breakdown of R&D Spending for Asia, Europe, Middle East & Africa, North America and South America
Omics Technology to Witness Rapid Growth
Adoption of Omics-based Technologies
Increasing Demand for 3D Cell Culture in Drug Discovery
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for Drug Discovery Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Drug Discovery Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Drug Discovery Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Small Molecule Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Small Molecule Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Small Molecule Drugs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Biologics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for High Throughput Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for High Throughput Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for High Throughput Screening by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Bioinformatics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Bioinformatics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Bioinformatics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Pharmacogenomics & Pharmacogenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Pharmacogenomics & Pharmacogenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pharmacogenomics & Pharmacogenetics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Nanotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Nanotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Nanotechnology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
UNITED STATES
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
USA Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027
JAPAN
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Japan Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027
CHINA
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
China Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027
EUROPE
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Europe Recent Past, Current & Future Analysis for Drug Discovery Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Drug Discovery Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Drug Discovery Technologies by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027
FRANCE
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
France Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027
GERMANY
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Germany Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027
UNITED KINGDOM
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
UK Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027
REST OF WORLD
Rest of World Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027
Rest of World Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027
Rest of World Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com